Liquid Biopsy Breakthrough – International Society of Liquid Biopsy – OncoDaily
Liquid Biopsy Breakthrough – International Society of Liquid Biopsy / cancer, Charles Abbott, Charles Swanton, ctDNA, Gabor Bartha, International Society of
Liquid Biopsy Breakthrough – International Society of Liquid Biopsy / cancer, Charles Abbott, Charles Swanton, ctDNA, Gabor Bartha, International Society of
As supported by data from the phase 3 TROPION-Breast01 trial, datopotamab deruxtecan is now an FDA-approved treatment for patients with HR-positive, HER2-negative breast cancer.
On January 17, 2025, the Food and Drug Administration approved datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo, Inc.), a Trop-2-directed antibody and topoisomerase inhibitor conjugate, for adult…
NSW has a critical and chronic shortage of mental health workers and the system can’t keep up with community needs.
Resources and articles from student service providers, faculty, staff, and current medical students on maintaining well-being during medical school.
Cancer mortali ty rates have been steadily declining in the United States for several decades; however, certain types of cancer remain stubbornly lethal, with the…
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data…
Justices reject Chinese app’s First Amendment challenge to federal law against “foreign adversary” control.
John Mandrola, Adam Cifu and Vinay Prasad answer
Background Health systems across Europe are facing a workforce crisis, with some experiencing severe shortages of doctors. In response, many are exploring greater task-sharing, across…
Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by the American Cancer Society.